OrbiMed Advisors LLC's Form 4 filing
Tricida, Inc. (TCDA) · filed Nov 25, 2022
- Accession no.
- 0000947871-22-001208
- Filed
- Nov 25, 2022, 8:13 PM ET
- Trade date
- Nov 22-25, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $2.21M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | Common Stock | SSaleDisposed | −1,034,421 | $0.22F1 | −$227,572.62 | 9,246,526 | Indirect | Duplicate filing |
| Nov 23, 2022 | Common Stock | SSaleDisposed | −5,617,300 | $0.21 | −$1,179,633 | 3,629,226 | Indirect | Duplicate filing |
| Nov 25, 2022 | Common Stock | SSaleDisposed | −3,629,226 | $0.22 | −$798,429.72 | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price of the shares of the Issuer's common stock ("Shares") sold, ranging from a low of $0.21 to a high of $0.22 per Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.